Search for: "Andersen v. United States" Results 161 - 165 of 165
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
22 Mar 2008, 2:00 am
: (IPBiz),US: Two remaining challenged WARF embryonic stem cell patents upheld in ex parte reexamination: (Holman's Biotech IP Blog), Pharma & Biotech - ProductsAricept (Donepezil) – USV wins appeal against USPTO decision: (Spicy IP),Celerex (Celecoxib) – CAFC decision in Celebrex patents dispute between Pfizer and Teva will cut patent term by one and a half years: (Patent Baristas), Inersan – Ranbaxy in-licenses Inersan to CD Pharma to market in India and… [read post]
1 Mar 2007, 4:57 am by Ricky E. Bagolie
If one class of proteins has more activity than the other class, an abnormal state exists and a person becomes either at risk of excessive clotting (thrombosis) or excessive bleeding. [read post]
29 Jan 2018, 11:28 pm by Kevin LaCroix
Some 40 or so years later, Chairman Clayton’s regeneration of Judge Sporkin’s gatekeeper liability lays the regulatory foundation for a successful and vast SEC ICO assault, which will leave some ICO lawyers looking over their shoulders, and others perhaps dashing for cover. 1970s:  SEC v. [read post]